We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.28T Turnover 24.66%
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+35.7%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$1.28T
AUM Growth
+$391B
Cap. Flow
+$19.1B
Cap. Flow %
1.49%
Top 10 Hldgs %
26.66%
Holding
15,023
New
1,956
Increased
5,793
Reduced
5,445
Closed
1,748
Avg Time Held Equity + Options
3.8 years
Top 10 Avg Time Held Equity + Options
5.1 years
Top 20 Avg Time Held Equity + Options
5.8 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.8 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.8%
2 Technology 2.93%
3 Communication Services 0.62%
4 Consumer Discretionary 0.61%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ATOS icon
13026
CALL
Atossa Therapeutics
ATOS
$19.6M
$21.8K ﹤0.01%
+11,300
New +$51.5K
2026 Q2
0 quarters
IVF icon
13027
INVO Fertility
IVF
$3.1M
$21.8K ﹤0.01%
+2,866
New +$20.6K
2026 Q2
0 quarters
FMST icon
13028
Foremost Lithium Resource & Technology
FMST
$11.7M
$21.7K ﹤0.01%
+14,868
New +$24.7K
2026 Q2
0 quarters
HIND icon
13029
Vyome Holdings
HIND
$11.1M
$21.6K ﹤0.01%
+10,058
New +$21.7K
2026 Q2
0 quarters
PPBT icon
13030
Purple Biotech
PPBT
$2.65M
$21.6K ﹤0.01%
12,847
-40,556
-76% -$137K
2025 Q4
2 quarters
XELB icon
13031
Xcel Brands
XELB
$2.31M
$21.6K ﹤0.01%
+11,985
New +$24K
2026 Q2
0 quarters
NGEN icon
13032
PUT
NervGen Pharma
NGEN
$202M
$21.4K ﹤0.01%
+10,400
New +$32.3K
2026 Q2
0 quarters
GIGM icon
13033
GigaMedia
GIGM
$15.1M
$21.2K ﹤0.01%
13,742
+2,076
+18% +$2.97K
2025 Q3
3 quarters
ASPSW icon
13034
Altisource Portfolio Solutions SA Net Settle Stakeholder Warrants
ASPSW
$8.17M
$21.1K ﹤0.01%
52,733
+16,234
+44% +$6.46K
2025 Q2
4 quarters
EONR icon
13035
EON Resources
EONR
$14.3M
$20.9K ﹤0.01%
+47,344
New +$31.4K
2026 Q2
0 quarters
LHAI icon
13036
Linkhome Holdings
LHAI
$13.6M
$20.8K ﹤0.01%
+31,523
New +$31.1K
2026 Q2
0 quarters
DRMA icon
13037
Dermata Therapeutics
DRMA
$3.06M
$20.6K ﹤0.01%
+15,989
New +$20.1K
2026 Q2
0 quarters
CRBU icon
13038
PUT
Caribou Biosciences
CRBU
$39.1M
$20.6K ﹤0.01%
11,700
-36,500
-76% -$72.1K
2024 Q4
6 quarters
GRMLW icon
13039
Greenland Mines Ltd Warrant
GRMLW
$20.6K ﹤0.01%
120,934
-80,272
-40% -$17.6K
2025 Q3
3 quarters
OLPX icon
13040
CALL
DELISTED
Olaplex Holdings
OLPX
$20.5K ﹤0.01%
10,000
-48,000
-83% -$97.8K
2026 Q1
1 quarter
MSC icon
13041
Studio City International Holdings
MSC
$184M
$20.5K ﹤0.01%
+11,192
New +$26.9K
2026 Q2
0 quarters
NNDM icon
13042
PUT
Nano Dimension
NNDM
$246M
$20.4K ﹤0.01%
14,100
+3,000
+27% +$4.9K
2020 Q4
22 quarters
REE icon
13043
DELISTED
REE Automotive
REE
$20.4K ﹤0.01%
+103,977
New +$47.4K
2026 Q2
0 quarters
VRXA icon
13044
Veraxa Biotech
VRXA
$157M
$20.4K ﹤0.01%
+10,833
New +$86.6K
2026 Q2
0 quarters
STIM icon
13045
CALL
Neuronetics
STIM
$134M
$20.3K ﹤0.01%
15,600
-19,900
-56% -$29K
2025 Q2
4 quarters
BBAI.WS icon
13046
BigBear.ai Holdings Warrant
BBAI.WS
$4.36M
$20.1K ﹤0.01%
56,727
+33,604
+145% +$17.2K
2025 Q4
2 quarters
FCRS.WS icon
13047
FutureCrest Acquisition Corp Warrants
FCRS.WS
$20K ﹤0.01%
+23,491
New +$17.7K
2026 Q2
0 quarters
VHUB icon
13048
VenHub Global
VHUB
$22M
$19.9K ﹤0.01%
+18,923
New +$20.2K
2026 Q2
0 quarters
SPWRW icon
13049
SunPower Inc Warrants
SPWRW
$357K
$19.8K ﹤0.01%
141,110
-11,002
-7% -$2.2K
2025 Q3
3 quarters
IHT icon
13050
InnSuites Hospitality Trust
IHT
$11.1M
$19.7K ﹤0.01%
+11,581
New +$15.3K
2026 Q2
0 quarters

Similar funds

Jeff Yass's Q2 2026 Portfolio in Review

As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q2 2026 filing shows 1,956 new, 5,793 increased, 5,445 reduced and 1,748 closed positions. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M. The largest sale was Invesco QQQ Trust, an estimated $1.78B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
  • Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
  • Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
  • Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
  • Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.